Full-Life Technologies key facts
- Developer of radiotherapeutic technologies focused on clinical-stage research, production, and commercialisation of radiopharmaceuticals.
- It has raised $187.7M; the latest was Later Stage VC ($77.0M) in Sep 2025.
- Notable investors include HSG (Hong Kong), Aramco Ventures, Sky9 Capital, Lapam Capital, Prosperity7 Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Who backs Full-Life Technologies
14+- ·The complete investor list: 14 names
- ·Watch Full-Life Technologies: the Monday email on marks, rounds and moves
Full-Life Technologies funding rounds
No funding rounds for Full-Life Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Full-Life Technologies investors
14 investors are on record for Full-Life Technologies, including HSG (Hong Kong), Aramco Ventures, Sky9 Capital and Lapam Capital. By type, the record holds 3 venture capital firms and 2 hedge funds.
About Full-Life Technologies
Developer of radiotherapeutic technologies focused on clinical-stage research, production, and commercialisation of radiopharmaceuticals. The company specializes in span radioisotope research, drug development and clinical deployment, serving integrated treatment innovation and addressing key challenges in radiopharmaceutical accessibility and effectiveness.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- full-life.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Full-Life Technologies doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.